Profile
Sandra Ramos-Alves holds current positions at multiple firms.
Since 2024, serving as President, Treasurer, and Director at Mirati Therapeutics, Inc. Also since 2024, holds the roles of Treasurer, Director, and Vice President at Rayzebio, Inc. Additionally, since 2024, serves as President, Treasurer, and Director at Karuna Therapeutics, Inc. Holds a Director position at Juno Therapeutics, Inc. Holds the roles of Chief Executive and Financial Officer at Turning Point Therapeutics, Inc.
Sandra Ramos-Alves active positions
| Companies | Position | Start |
|---|---|---|
| TURG POIN | Chief Executive Officer | - |
| MIRATI THERAPEUTICS | President | 23/01/2024 |
| RAYZEBIO, INC. | Director/Board Member | 26/02/2024 |
| KARA THER | President | 18/03/2024 |
| JUNO THERAPEUTICS INC | Director/Board Member | - |
Experiences
Positions held
Active
Inactive
Listed companies
Private companies
Connections
1st degree connections
1st degree companies
Male
Female
Members of the board
Executives
Linked companies
| Private companies | 5 |
|---|---|
Turning Point Therapeutics, Inc.
Turning Point Therapeutics, Inc. Pharmaceuticals: MajorHealth Technology Operates as clinical-stage structure-based drug design company for discovery and development of precision medicines for cancer and other diseases | Health Technology |
Mirati Therapeutics, Inc.
Mirati Therapeutics, Inc. Pharmaceuticals: MajorHealth Technology Operates as a clinical-stage biopharmaceutical company that develops cancer therapies | Health Technology |
Karuna Therapeutics, Inc.
Karuna Therapeutics, Inc. Pharmaceuticals: MajorHealth Technology Operates as a biopharmaceutical company that develops medicines for psychiatric and neurological disorders like schizophrenia and Alzheimer’s disease | Health Technology |
Juno Therapeutics, Inc.
Juno Therapeutics, Inc. BiotechnologyHealth Technology Operates as a biopharmaceutical company to treat cancer, HIV and cardiovascular diseases | Health Technology |
Rayzebio, Inc.
Rayzebio, Inc. Pharmaceuticals: MajorHealth Technology Develops radiopharmaceutical therapeutics for cancer treatment | Health Technology |
- Stock Market
- Insiders
- Sandra Ramos-Alves
















